寵物糖尿病護理設備市場規模、佔有率和成長分析：按產品類型、動物種類、應用、最終用戶、分銷管道、技術和地區分類－2026-2033年產業預測

2024 年全球寵物糖尿病護理設備市場價值為 25 億美元，預計到 2025 年將成長至 26.7 億美元，到 2033 年將成長至 44.8 億美元，預測期（2026-2033 年）複合年成長率為 6.7%。

全球寵物糖尿病照護設備市場的主要驅動力是伴侶動物糖尿病發生率的不斷上升，而這又受到老化、肥胖等因素的影響，以及獸醫篩檢體系的不斷改進。該市場涵蓋血糖值監測儀、胰島素注射系統和整合軟體，這些都是有效管理寵物血糖值的關鍵設備。更完善的監測不僅可以最大限度地減少併發症，延長寵物壽命，還能降低整體治療成本。近期技術進步推動了持續血糖監測和遠距遠端醫療解決方案的發展，使居家監測成為可能。此外，人工智慧創新透過整合持續感測和預測分析，提高了護理質量，使獸醫的遠端系統管理更加便利。寵物保險的普及和都市區寵物飼養量的增加也促進了市場需求，為醫療設備製造商和獸醫之間的合作創造了廣闊的前景。

全球寵物糖尿病護理設備市場的成長要素

寵物糖尿病照護設備的需求主要源於飼主對這種疾病及其長期健康影響的認知不斷提高。隨著飼主對相關知識的了解日益加深，他們更願意尋求診斷，並增加對家庭監測解決方案的投入。宣傳活動、獸醫指導以及飼主之間的經驗共用，都在提高人們對糖尿病症狀的認知，並強調持續血糖監測和胰島素注射工具的重要性，從而促進了相關產品的購買。這種參與度的提高推動了疾病的常規管理，鼓勵了這些設備的持續使用，並激勵了方便用戶使用型技術的研發，最終加速了市場成長和創新。

全球寵物糖尿病護理設備市場的限制因素

全球寵物糖尿病護理設備市場面臨高昂的採購價格和持續高企的供應成本等諸多限制因素，阻礙了寵物飼主和獸醫診所的採用。在伴侶動物慢性病保險覆蓋範圍有限的地區，這個問題尤其突出。高昂的整體擁有成本使得投資者對投資先進的監測技術和胰島素輸注系統猶豫不決，導致用戶傾向於選擇更經濟實惠的手動方法。此外，小規模獸醫診所和注重預算的寵物飼主面臨的經濟壓力進一步阻礙了市場滲透，導致高階設備需求有限，最終限制了收入成長和更廣泛的商業化。

全球寵物糖尿病護理設備市場趨勢

全球寵物糖尿病護理設備市場正呈現向整合監測平台發展的顯著趨勢，旨在提升寵物糖尿病的管理水平。市場對能夠整合連續血糖監測、雲端連接和簡化獸醫工作流程的互操作系統的需求日益成長。製造商正致力於開發可實現無縫資料共用和遠端監測的設備，並為飼主提供使用者友善的護理介面。這一趨勢促進了設備開發商、軟體提供者和獸醫醫院之間的合作，從而能夠創建全面的護理路徑，並透過及時的警報提高治療依從性。此外，它還允許在不增加獸醫團隊工作負擔的情況下進行個人化治療調整。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球寵物糖尿病護理設備市場規模：依產品類型分類

• 血糖值測量裝置
  • 攜帶式血糖儀
  • 連續血糖監測設備
  • 試紙和採血針
  • 其他
• 胰島素輸送裝置
  • 胰島素筆
  • 胰島素注射器
  • 胰島素幫浦
  • 其他
• 糖尿病管理軟體和應用程式
• 其他

全球寵物糖尿病護理設備市場規模：以動物類型分類

• 狗
• 貓
• 其他

全球寵物糖尿病護理設備市場規模：按應用領域分類。

• 血糖值監測
• 胰島素給藥
• 糖尿病管理與追蹤
• 其他

全球寵物糖尿病護理設備市場規模：依最終用戶分類

• 動物醫院
• 動物診所
• 居家照護環境
• 動物收容所
• 其他

全球寵物糖尿病護理設備市場規模：按分銷管道分類

• 獸醫醫院和獸醫診所
• 零售藥房
• 線上零售
• 其他

全球寵物糖尿病護理設備市場規模：依技術分類

• 傳統監測設備
• 智慧型互聯設備
• 穿戴式監測設備

全球寵物糖尿病護理設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Abbott Laboratories
• Dexcom
• Roche Diagnostics
• i-SENS
• Trividia Health
• Medtronic
• Bayer
• UltiMed
• VetMate
• ALR Technologies
• Nova Biomedical
• Ypsomed
• Allison Medical
• PetTest
• Acon Laboratories
• TaiDoc Technology
• Apacor

結論與建議

Global Pet Diabetes Care Devices Market size was valued at USD 2.5 Billion in 2024 and is poised to grow from USD 2.67 Billion in 2025 to USD 4.48 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global pet diabetes care devices market is primarily driven by the increasing incidence of diabetes in companion animals, influenced by factors like aging populations and obesity, coupled with enhanced veterinary screening practices. This market encompasses glucose monitors, insulin delivery systems, and connected software, all essential for effective glycemic management in pets. Improved monitoring not only minimizes complications and extends pet lifespan but also reduces overall treatment costs. Recent advancements in technology have led to a transition towards continuous glucose monitors and telehealth solutions, enabling practical at-home monitoring. Additionally, AI innovations are enhancing care by integrating continuous sensing with predictive analytics, facilitating remote veterinary oversight. The surge in pet insurance and urban pet ownership also fosters demand, creating fruitful opportunities for device manufacturers and veterinary partnerships.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pet Diabetes Care Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pet Diabetes Care Devices Market Segments Analysis

Global pet diabetes care devices market is segmented by by product type, by animal type, by application, by end user, by distribution channel, by technology and region. Based on by product type, the market is segmented into Blood Glucose Monitoring Devices, Insulin Delivery Devices, Diabetes Management Software & Apps and Others. Based on by animal type, the market is segmented into Dogs, Cats and Others. Based on by application, the market is segmented into Blood Glucose Monitoring, Insulin Administration, Diabetes Management & Tracking and Others. Based on by end user, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Homecare Settings, Animal Shelters and Others. Based on by distribution channel, the market is segmented into Veterinary Clinics & Hospitals, Retail Pharmacies, Online Retail and Others. Based on by technology, the market is segmented into Conventional Monitoring Devices, Smart Connected Devices and Wearable Monitoring Devices. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pet Diabetes Care Devices Market

The demand for devices catering to pet diabetes care is significantly fueled by the growing awareness among pet owners regarding the condition and its long-term health effects. As owners become more informed, they are increasingly motivated to seek diagnoses and invest in home-use monitoring solutions. Educational initiatives, veterinary guidance, and shared experiences among pet owners enhance the recognition of diabetes symptoms and highlight the importance of continuous glucose monitoring and insulin delivery tools, leading to increased purchases. This heightened engagement fosters regular disease management, promotes consistent use of these devices, and encourages the development of user-friendly technologies, ultimately boosting market growth and innovation.

Restraints in the Global Pet Diabetes Care Devices Market

The Global Pet Diabetes Care Devices market faces significant constraints due to high purchase prices and persistent supply costs, which hinder adoption among pet owners and veterinary practices. This issue is particularly pronounced in areas where insurance coverage for chronic conditions in companion animals is minimal. The perceived high total cost of ownership often leads to a reluctance to invest in advanced monitoring technologies and insulin delivery systems, driving users towards more affordable manual methods. Additionally, financial restrictions experienced by smaller clinics and budget-conscious pet owners further impede market penetration, resulting in limited demand for premium devices and ultimately restricting revenue growth and broader commercialization initiatives.

Market Trends of the Global Pet Diabetes Care Devices Market

The Global Pet Diabetes Care Devices market is witnessing a significant trend towards integrated monitoring platforms, which enhance the management of diabetes in pets. The demand for interoperable systems combining continuous glucose sensing, cloud connectivity, and streamlined veterinary workflows is on the rise. Manufacturers are focusing on creating devices that facilitate seamless data sharing and remote monitoring capabilities, empowering pet owners with easy-to-use caregiver interfaces. This trend fosters collaborations among device developers, software providers, and veterinary clinics, enabling comprehensive care pathways and improving adherence through timely alerts, while allowing for personalized treatment adjustments without complicating the operations for veterinary teams.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pet Diabetes Care Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Blood Glucose Monitoring Devices
  • Handheld Glucose Meters
  • Continuous Glucose Monitoring Devices
  • Test Strips & Lancets
  • Others
• Insulin Delivery Devices
  • Insulin Pens
  • Insulin Syringes
  • Insulin Pumps
  • Others
• Diabetes Management Software & Apps
• Others

Global Pet Diabetes Care Devices Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Others

Global Pet Diabetes Care Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Blood Glucose Monitoring
• Insulin Administration
• Diabetes Management & Tracking
• Others

Global Pet Diabetes Care Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Homecare Settings
• Animal Shelters
• Others

Global Pet Diabetes Care Devices Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics & Hospitals
• Retail Pharmacies
• Online Retail
• Others

Global Pet Diabetes Care Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Conventional Monitoring Devices
• Smart Connected Devices
• Wearable Monitoring Devices

Global Pet Diabetes Care Devices Market Size & CAGR (2026-2033)

• North America (By Product Type, By Animal Type, By Application, By End User, By Distribution Channel, By Technology)
  • US
  • Canada
• Europe (By Product Type, By Animal Type, By Application, By End User, By Distribution Channel, By Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Product Type, By Animal Type, By Application, By End User, By Distribution Channel, By Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Product Type, By Animal Type, By Application, By End User, By Distribution Channel, By Technology)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Animal Type, By Application, By End User, By Distribution Channel, By Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• i-SENS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UltiMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetMate
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALR Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allison Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetTest
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acon Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TaiDoc Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apacor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations